2021: The Milestone Year

OnMarket

OnMarket’s Capital Report - a must-read for 2022

OnMarket's 2021 Capital Report

2021 was another COVID19 impacted year; with toilet paper shortages, many online meetings, and low interest rates encouraging new investors to enter the Equity Markets. Throughout the chaos of it all, OnMarket is humbled and grateful to have reached another important milestone – raising $172m, from 66,000 investors, for 220 Australian businesses.

In light of this milestone, OnMarket created a behind-the-scenes video for those that made this achievement possible.

Click the image on the left to hear from the OnMarket team!

That’s not all! In the spirit of ‘new year new me’, OnMarket created an inaugural yearly resource – summarising all platform activities throughout 2021. The Capital Report analyses the investment opportunities provided to investors, their returns, hot sectors, and the capital raised for many incredible Australian businesses across a diverse range of sectors.

To download the 2021 Capital Report, please follow the link below.

Discover investment opportunities here.

 

NASDAQ IPO Offer Closed

GenEmbryomics Ltd NASDAQ: XGEN

Providing next generation genetic testing for the global IVF industry

 

Nasdaq IPO only open to Professional, Sophisticated and Experienced investors

 

GenEmbryomics Ltd (NASDAQ: XGEN) is an Australian genomics-based company providing the ability to screen IVF embryos for over 3,200 severe and fatal genetic diseases. Their flagship test provides genetic testing via whole genome sequencing reducing the risk of having a child with a genetic disorder. Targeting the US$36bn global assisted fertility market, the test is being commercialised in the US with Progenesis Inc., a global fertility services provider.

$1.00Price
Up to US$5.2 millionSize of Offer
21 Mar 25Offer Open
28 Mar 25Pay By
CSF Register for early access

CHEFIN Australia Pty Ltd

Reshaping the ever-growing private dining market

 

CHEFIN brings diners and top private chefs together to create unforgettable dining experiences, backed by a scalable and proven business model. Since its inception, CHEFIN has generated $6M in revenue, built a network of 1,035 C-level chefs, and successfully hosted 3,000 bookings for over 118,580 diners.

CSF Closed Mar 2025

Prohibition Liquor Co. Ltd

The Prohibition Liquor Co. Ltd CSF offer has closed successfully. Prohibition has grown into one of Australia’s most awarded and respected distilleries, earning hundreds of international accolades. They are now embarking on an exciting new chapter—expanding to the historic Seppeltsfield Distillery in the Barossa Valley

Fully Funded

$2.61 million

Raised

1,128

Investors